Provention Bio, Inc.
Provention Bio, Inc. (PRVB) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PRVB · as of Jun 30, 2023
Ownership Breakdown
2
Institutional Holders
▼ 199 vs Q1
$3.42M
Total Inst. Value
▼ $1.47B vs Q1
95.09M
Shares Outstanding
freeFloat 73.20%
141,840
13F Shares Held
▼ 60.90M vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PRVB largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
UBS ASSET MANAGEMENT AMERICAS INC pharmaceutical preparations | 116.3K | 15.57% | 15.57% | $2.80B | Aug 11, 2023 | — held |
TEACHER RETIREMENT SYSTEM OF TEXAS pharmaceutical preparations | 25.5K | 3.41% | 3.41% | $615.00M | Jul 17, 2023 | — held |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 10, 2023 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 15, 2023 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 11, 2023 | EXIT |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
FMR LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 11, 2023 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares48
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-48
0 new / 48 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PRVB insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
74
Sell transactions
0.04
Buy/Sell ratio
$42M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sessa Capital (Master), L.P. 10 percent owner | Apr 27, 2023 | U-Tender | 15,567,497 | $0.00 | $1.6K | 0 | Form 4 ↗ |
Wysenski Nancy director | Apr 27, 2023 | D-Return | 128,981 | $13.16 | $1.70M | 0 | Form 4 ↗ |
Wysenski Nancy director | Apr 27, 2023 | D-Return | 22,200 | $12.62 | $280.2K | 0 | Form 4 ↗ |
Wysenski Nancy director | Apr 27, 2023 | D-Return | 23,000 | $6.80 | $156.4K | 0 | Form 4 ↗ |
Wysenski Nancy director | Apr 27, 2023 | D-Return | 33,000 | $4.52 | $149.2K | 0 | Form 4 ↗ |
Pisano Wayne director | Apr 27, 2023 | D-Return | 33,000 | $4.52 | $149.2K | 0 | Form 4 ↗ |
Pisano Wayne director | Apr 27, 2023 | D-Return | 23,000 | $6.80 | $156.4K | 0 | Form 4 ↗ |
Pisano Wayne director | Apr 27, 2023 | D-Return | 24,000 | $12.54 | $301.0K | 0 | Form 4 ↗ |
Pisano Wayne director | Apr 27, 2023 | D-Return | 128,981 | $4.00 | $515.9K | 0 | Form 4 ↗ |
Pisano Wayne director | Apr 27, 2023 | D-Return | 22,200 | $12.62 | $280.2K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Provention Bio, Inc. (PRVB) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 26.80%, while retail and public investors account for the remaining 73.05%.
The largest institutional shareholder of Provention Bio, Inc. is UBS ASSET MANAGEMENT AMERICAS INC, holding approximately 116,324 shares — equal to 15.57% of outstanding shares — as of June 30, 2023.
A total of 2 institutional investors currently hold PRVB stock, with a combined institutional value of approximately $3,418,407 as of the most recent 13F filing period.
Frequently asked questions
PRVB ownershipProvention Bio, Inc. (PRVB) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is UBS ASSET MANAGEMENT AMERICAS INC with a 15.57% stake. Company insiders hold 26.80%. Data sourced from SEC Form 13F as of June 30, 2023.